| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Applied Therapeutics Inc (NASDAQ: APLT)
APLT Technical Analysis
5
| As on 9th Jun 2023 APLT STOCK Price closed @ 1.47 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.95 & Strong Sell for SHORT-TERM with Stoploss of 3.99 we also expect STOCK to react on Following IMPORTANT LEVELS. |
APLTSTOCK Price
| Open | 1.47 | Change | Price | % |
| High | 1.51 | 1 Day | 0.00 | 0.00 |
| Low | 1.41 | 1 Week | 0.18 | 13.95 |
| Close | 1.47 | 1 Month | -0.19 | -11.45 |
| Volume | 191000 | 1 Year | -8.52 | -85.29 |
| 52 Week High 9.99 | 52 Week Low 0.54 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| APLT Daily Charts |
APLT Intraday Charts |
Whats New @ Bazaartrend |
APLT Free Analysis |
|
|
APLT Important Levels Intraday
| RESISTANCE | 1.66 |
| RESISTANCE | 1.60 |
| RESISTANCE | 1.56 |
| RESISTANCE | 1.52 |
| SUPPORT | 1.42 |
| SUPPORT | 1.38 |
| SUPPORT | 1.34 |
| SUPPORT | 1.28 |
APLT Forecast April 2024
| 4th UP Forecast | 5.88 |
| 3rd UP Forecast | 4.47 |
| 2nd UP Forecast | 3.59 |
| 1st UP Forecast | 2.72 |
| 1st DOWN Forecast | 0.22 |
| 2nd DOWN Forecast | -0.65 |
| 3rd DOWN Forecast | -1.53 |
| 4th DOWN Forecast | -2.94 |
APLT Weekly Forecast
| 4th UP Forecast | 9.72 |
| 3rd UP Forecast | 7.07 |
| 2nd UP Forecast | 5.44 |
| 1st UP Forecast | 3.80 |
| 1st DOWN Forecast | -0.86 |
| 2nd DOWN Forecast | -2.50 |
| 3rd DOWN Forecast | -4.13 |
| 4th DOWN Forecast | -6.78 |
APLT Forecast2024
| 4th UP Forecast | 20.03 |
| 3rd UP Forecast | 14.08 |
| 2nd UP Forecast | 10.4 |
| 1st UP Forecast | 6.72 |
| 1st DOWN Forecast | -3.78 |
| 2nd DOWN Forecast | -7.46 |
| 3rd DOWN Forecast | -11.14 |
| 4th DOWN Forecast | -17.09 |
Applied Therapeutics Inc ( NASDAQ USA Symbol : APLT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
APLT Business Profile
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase I/II for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York. Address: 545 Fifth Avenue, New York, NY, United States, 10017
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service